Clinical Trial Update: Carvedilol for the Prevention of Anthracycline/Anti-HER2 Therapy Associated Cardiotoxicity Among Women With HER2-Positive Breast Cancer Using Myocardial Strain Imaging for Early Risk Stratification [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating carvedilol to prevent cardiotoxicity from anthracycline and anti-HER2 therapy in women with HER2-positive breast cancer, using myocar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CARVEDILOL (Carvedilol)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2022-07-12